- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 685
Merck, Novo and Novartis back Forendo series A
Forendo, which is developing treatments for endometriosis and low testosterone, has closed its second round of funding.
Oct 28, 2014Anti-allergen developer DBV goes public
The corporate-backed company, which is developing treatments for peanut and milk allergies, secured $92.6m after raising approximately $50m in venture funding.
Oct 28, 2014Kaunas ventures forward with Practica
Kaunas University of Technology and Practica Capital have signed a co-operation agreement.
Oct 28, 2014Fund in the News: CommerzVentures
Commerzbank's newly formed fintech fund will invest from series A to C stage in Europe and the US, and could partner with the bank's existing incubator.
Oct 27, 2014Iversity educates $6.4m
Edtech Iversity raises money from investors including Deutesch Telekom.
Oct 27, 2014Google Ventures expands European Fund to $125m
Google Ventures has increased the size of its European start-up fund from $100m to $125.
Oct 24, 2014Imperial innovates $306m
Imperial Innovations has a full pot of cash following its IPO successes of Circassia and Abzena.
Oct 24, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


